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6INTRODUCTION
Sepsis  is  a  complex  syndrome  caused  by  an  uncontrolled 
inflammatory  response  (SIR),  of  infectious  origin,  characterized  by 
multiple manifestations which can result in dysfunction or failure of one 
or more organs and even death.64  
Neonatal sepsis is a clinical syndrome characterized by systemic 
signs of infection in the first month of life.
Globally, WHO estimates 5 million neonatal deaths a year. 98% of 
these occur in developing countries. The commonest etiology is sepsis 
which constitutes more than one third of the causes.64
Neonatal  septicemia  is  an  important  cause  of  morbidity  and 
mortality  among  neonates  in  India,  with  an  estimated  incidence  of 
approximately 4% in intramural live births.56
The  spectrum  of  pathogens  analyzed  from  hospital  based  data 
collected by National Neonatal Perinatal Database network from different 
centres in our country includes Klebsiella pneumoniae, Escherichia coli, 
Pseudomonas  aeroginosa,  Enterobacter  spp  and  Acinetobacter. Other 
pathogens  contributing  to  neonatal  sepsis  includes  Staphylococcus 
aureus, Streptococcus viridians and Candida species.47
Systemic  infections  due  to  pathogenic  fungi  are  also  assuming 
increasing importance in the neonatal intensive care units.   The NICU 
7babies  become  colonized  very  early.  About  10%  of  these  babies  get 
colonized in the first week of life and about 64% babies get colonized by 
4 weeks of hospital stay24. Among pathogenic fungi responsible for NICU 
outbreaks, C.albicans, C.parapsilosis and C.tropicalis are notorious.
Several  factors  contribute  to  the  frequency  and  severity  of 
neonatal infection and emphasize the importance of early accurate 
diagonosis and appropriate treatment.
1. The  presenting  clinical  manifestations  in  neonates  with 
infection may mimic the features of other diseases, hence the 
diagnosis is delayed till the infection becomes severe.
2. The newborns especially  preterm,  have an immature immune 
system which is easily over come by invading organisms. 
3. With the improvement of neonatal Intensive care, the survival 
rate of preterm and low birth weight newborn have increased. 
They form a high risk group for infection.
4. A variety  of  aetiological  agents  including  bacteria,  viruses, 
fungi, protozoa and mycoplasma can cause infection.
5. The laboratory tests available for diagnosis do not provide rapid 
result needed for early and quick appropriate treatment.
6. Infection  caused  by  multidrug  resistant  organisms  have 
increased, further complicating the management.
8AIMS AND OBJECTIVES
1. To identify the bacterial and fungal agents causing sepsis in the 
newborn.
2. To study the antimicrobial susceptibility pattern of the isolates 
with a view to formulate an empiric antibiotic regimen.
3. To detect emerging pattern of resistance in these organisms by 
standard methods.
4. To know the prevalence of Extended spectrum beta lactamases 
production in gram negative bacteria.
9REVIEW OF LITERATURE
Definition
Neonatal septicemia is a disease of infants who are less than one 
month of age, are clinically ill and have positive blood culture76
Neonatal  Sepsis can be divided into 2 subtypes depending upon 
whether the onset of symptoms is before 72 hrs of life (early onset) or 
later (late onset).
Early onset septicemia
It is caused by organisms prevalent in genital tract or in the labour 
room and maternity operation theatre47.
Late onset septicemia
It  is  acquired  after  delivery  in  the  normal  new  born  nursery 
neonatal intensive care unit or the community57. The onset of symptoms 
is  usually  delayed  beyond  72hrs  after  birth.In  most  cases,  symptoms 
appear by the end of first week or during second week of life.
Epidemiology
The  incidence  of  neonatal  sepsis  according  to  the  data  from 
National  Neonatal  Perinatal  Database  (NNPD,  2002-2003)56 is  30  per 
1000 live births. The database comprising 18 tertiary care neonatal units 
across India found that septicemia was the commonest clinical category 
with  an  incidence  of  23  per  1000  live  births,  while  the  incidence  of 
meningitis was reported to be 3 per 1000 live births. Among intramural 
births, Klebsiella  pneumoniae was the most frequently isolated pathogen 
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(32.5%) followed by Staphylococcus aureus (13.6%). Among  extramural 
neonates  (referred  from  community/other  hospitals)  Klebsiella  
pneumoniae was  again  the  commonest  organism  (27%)  followed  by 
Staphylococcus aureus (15%) and Pseudomonas (13%). 
The  incidence of sepsis varies from 7.142 to 3882 per  1000 live 
births in Asia; 6.5 to 23/1000 live births in Africa, 3.549- 8.968 per 1000 
live births in South America and carribeans; 6 per 1000 live births in USA 
and Australia.64
Pathogenesis of Neonatal infection
The  fetus  normally  encounters  no  microorganisms  during 
development and the newborn infant becomes harmlessly colonized by 
bacteria  acquired  from  the  birth  canal  and  the  environment.  This  is 
because  of  the  barrier  to  infection  provided  by  the  placenta  and 
membranes, the low pathogenicity of colonizing microorganisms and the 
relative competence of the baby’s defense mechanisms. It is usually when 
one or  other  of  these factors is  altered that  fetal  or  neonatal  infection 
occurs.
Colonization of Healthy Infants
The nature of colonizing organisms is determined by the pattern of 
flora in the birth canal and in the environment. Babies born at home are 
colonized  by  organisms,  derived  primarily  from  the  mother.  These 
organisms  and  those  acquired  from  family  members,  tend  to  be 
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community  derived  antibiotic-sensitive  organisms,  of  limited 
pathogenicity.
In the postnatal  ward, the baby will  acquire organisms from the 
ward environment, other babies and the clinical staff.
Colonization of intestinal tract
The predominant intestinal organisms acquired by normal babies 
are members of the family Enterobacteriacea (including E coli,Klebsiella 
spp and Citrobacter spp) 
Colonization of respiratory tract:
Colonization of the upper respiratory tract occurs rapidly and 90% 
of infants have positive pharyngeal cultures by the third day. Coagulase-
negative  staphylococci  are  the  commonest,  followed  by  Streptococcus 
viridans and Staphylococcus aureus.
Colonization of skin
Skin  colonization  is  very  rapid,  with  the  number  of  bacteria 
increasing  100  fold  during  the  first  week.  Coagulase-negative 
staphylococci predominate but Staphylococcus aureus may be found in 
65% of infants. A host of other organisms can be found, including yeasts 
and a range of saprophytic bacteria. The Umblicus, perineum and axillae 
are the most heavily colonized.
Colonization of infants on a neonatal intensive care unit:
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These  babies  are  at  greatest  risk  of  becoming  colonized  by 
pathogens,  which  often  show  resistance  to  antibiotics.  The  pattern  of 
bowel  colonization  is  very  different  among  sick  preterm  infants. 
Coagulase negative staphylococcus and antibiotic resistant gram negative 
organisms predominate.18,19
Skin colonization on the NICU is mainly by Coagulase negative 
staphylococcus,  which  can  be  isolated  from over  90% of  all  positive 
cultures.  Staphylococcus  epidermidis accounts  for  80%  and 
Staphylococcus haemolyticus for almost all of the remainder.10
Balance between colonization and infection
Most babies become colonized without becoming infected, but in 
others various host factors  or the pathogenicity of the organisms result in 
tissue invasion and sepsis.
Intact skin and mucous membranes present an important barrier to 
microorganisms. Abrasions and cuts, mucosal injury, cannulae, catheters 
and endotracheal tubes all open the way for bacterial invasion.
Certain infective agents have an inherent ability to penetrate the 
placental  barrier,  often  damaging  the  placenta.  Ascent  of  the  vaginal 
organisms into the uterine cavity prior to rupture of the membranes is 
rare. Once the membranes rupture, the risk increases progressively with 
time.
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Vaginal  delivery  inevitably  results  in  contamination  and  the 
beginning of colonization of the skin and the gut of the baby. Vaginal 
flora vary considerably from woman to woman and many cases of early 
onset  neonatal  sepsis  result  from the  vaginal  carriage of  opportunistic 
pathogens.
In addition to the organisms acquired during birth all babies are 
subject to further microbiological contamination from the environment. 
People are the main source of such contamination.
Babies are less able to combat infection than the older children. 
This is further compromised by prematurity.
Competition  between  bacteria  is  a  controlling  influence  on  the 
level of colonization and risk of infection. The competitive inhibition of 
gram-negative organisms by lactobacillus bifidus in the gut of the breast 
fed infants.29
The various risk factors involved in neonatal sepsis are low birth 
weight85,  prolonged  rupture  of  membranes91,  difficult  delivery  and 
instrumentation,  birth  asphyxia,  difficult  resuscitation35,  ventilator 
therapy50,  intravenous catheterization35 and administration of parenteral 
nutrition86
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PATHOGENESIS OF SEPSIS
Infection  begins  when  microorganisms  circumvent  or  penetrate 
host barriers such as skin and mucosa. Depending on the infecting agents, 
virulence and immunocompetence of the patient, local host defenses may 
be  overwhelmed,  resulting  in  microbial  invasion  of  the  bloodstream. 
Toxic  products  released  by  the  microbes  in  the  circulation  activate 
systemic  host  defenses,  including  plasma  factors  (Complement  and 
clotting  cascades)  and  cellular  components  (neutrophils,  monocytes, 
macrophages  and  endothelial  cells).  In  turn,  activated  cells  produce 
potentially toxic mediators that augment the inflammatory response. This 
escalating immune response in concert with microbial toxins can lead to 
shock, multiple organ failure and death.11
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PATHOGENESIS OF SEPSIS
Aetiological agents
Gram positive bacteria Fungal agents 
Staphylococcus aureus Candida 
albicans
Staphylococcus epidermidis Candida parapsilosis66
Streptococcus agalactiae91 Candida tropicalis17
Listeria monocytogenes3 Malassezia furfur7
Malassezia pachydermatis23
Microbial toxins
Infection
Host defense system activated
Inflammatory response
Excessive Inadequate
Survival
Adequate
Uncontrolled 
infection ongoing 
release of microbial 
toxins
Controlled 
infection 
microbiological 
toxins cleared or 
neutralized
Death
Tissue injury
Shock and multiorgan 
failure
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Aspergillus fumigatus46
Gram negative bacteria
         Klebsiella pneumoniae
Escherichia coli
Pseudomonas aeroginosa
Hemophilus influenzae 
Acinetobacter spp
Enterobacter aerogenes58
Anaerobes
Anaerobes have a role in causing early onset neonatal septicemia 
(Mitra S et al 1997).48 Yohannan MD et al93 1992 stated that congenital 
pneumonia  and  early  onset  septicemia  were  caused  by  Bacteroides 
fragilis. 
Gram positive organisms
        In the 1950s, phage group I Staphylococcus aureus was the most 
common  bacterial  agent  that  caused  septicemia  in  neonatal  units.  Its 
unique invasive properties caused disseminated disease with widespread 
manifestations, including neonatal mastitis, furunculosis, septic arthritis, 
osteomyelitis and septicemia.
Methicillin-resistant organisms are an increasing problem in both 
neonatal  and  adult  intensive  care  units  and  require  treatment  with 
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vancomycin. MRSA can be spread within Neonatal Intensive Care Unit in 
epidemic  and  endemic  fahion.  Infection  control  measures  including 
identification of colonized infants by routine surveillance and cohorting 
and isolation of colonized infants may be required to prevent spread and 
persistence of the organism32.
Neonatal  GBS  infection  is  acquired  in  utero  or  during  passage 
through the birth canal.because not all women are colonized with GBS, 
documented  colonization  with  GBS is  the  strongest  predictor  of  GBS 
Early onset  sepsis.  Heavy maternal colonisation [vaginal inoculum 105 
colony forming units(cfu)/ml]with GBS is associated with a higher risk of 
invasive disease.
Among  the  Coagulase  negative  staphylococcus,  Staphylococcus 
epidermis is  the  primary  cause  of  NICU disease.  Coagulase  negative 
staphylococci   universally colonize the skin of NICU patients. They are 
believed to cause bacteremia by first colonizing the surfaces of central 
catheters.32
Gram negative organisms
        Sepsis with  Gram negative  microorganisms is increasingly reported 
nowadays  particularly in Asian countries12,33.The inadvertant use of broad 
spectrum antibiotics has led to the emergence of multi drug resistant gram 
negative bacteria37. Klebsiella species are of significant importance in this 
regard.69
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Escherichia coli is  another common gram negative bacteria  that 
causes  septicemia  during  neonatal  period.Approximately  40%  of 
Escherichia  coli stains  that  cause  septicemia  possess  K1  capsular 
antigen.92
In the newborns who receive broad spectrum antibiotics while in 
an  environment  that  is  potentially  contaminated  by  bacteria  from 
respirators or moist oxygen, the disease is most likely to be caused by 
Pseudomonas species92
Acinetobacter species  is  an  important  emerging  nosocomial 
pathogen in neonatal septicemia25,88. Septicemia due to Acinetobacter spp 
are  common  in  babies  with  predisposing  factors  like  endotracheal 
intubation and artificial ventilation12.other gram negative bacteria include 
Proteus species, Enterobacter species and Citrobacter species.
EXTENDED SPECTRUM BETA LACTAMASES
       In  septicemic  neonates,  positivity  of  blood  culture  exhibits 
predominantly   multi  drug  resisitant  gram  negative  rods  among  the 
isolates29
Multidrug  resistant  gram  negative  bacteria  are  associated  with 
production of Extended spectrum beta lactamases.As these enzymes are 
active  against  narrow  spectrum  cephalosporins,  Extended  spectrum 
cephalosporins, astreonam, the treatment becomes more problematic.62 
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Several  outbreaks of infection caused by  Klebsiella pneumoniae 
isolates that are simultaneously resistant to broad spectrum  beta lactam 
antibiotics74. Studies carried out in various parts of India have reported 
prevalence of ESBL producing Klebsiella isolates.26
Jain  et  al  observed  ESBL  production  in  87.2%  isolates  of 
Klebsiella species, 65.3% isolates of  Escherichia coli and 33.3% isolates 
of  Pseudomonas aeroginosa. 27 
CANDIDA INFECTIONS
Systemic candidiasis is a serious form of nosocomial infection in 
Very low birth weight  infants. Recent data on late-onset sepsis from the 
NICHD Neonatal Research Network showed that 12% of cases of late-
onset sepsis were caused by fungal species, primarily Candida albicans 
and Candida parapsilosis, and one-third of those infants died.
Risk factors for colonization and invasive diseases are similar. The 
administration of parenteral nutrition and intralipid infusions and the use 
of  H2 blockers, systemic steroids and 3rd generation cephalosporins have 
been  identified  as  independent  risk  factors  for  the  development  of 
invasive fungal infection30.
Apart from these factors low birth weight,pre maturity and intra 
venous catheterization makes neonates prone to candidemia20,80,78
There  is  some  evidence  showing  a  correlation  between  fungal 
colonization and invasive disease in very low birth weight babies6,40
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CLINICAL FEATURES
Non-Specific features of sepsis are
1. Hypothermia or fever,
2. Lethargy, poor cry, refusal to suck.
3. Poor perfusion, prolonged capillary refill time
4. Hypotonia, absent neonatal reflexes 
5. Bradycardia / tachycardia 
6. Repiratory distress, apnoea and gasping respiration 
7. Hypoglycemia / Hyperglycemia
8. Metabolic acidosis.
Specific features, related to various systems are
CNS : Bulging anterior fontanelle, vacant stare, high-pitched cry, 
excess irritability, stupor /  coma, seizures,  neck retraction. Presence of 
these features should raise a clinical suspicion of meningitis. 
Cardiovascular system: Hypotension, poor perfusion, shock.
GIT: Feed  intolerance,  Vomiting,  Diarrhoea,  Abdominal 
distension, Paralytic Ileus, Necrotizing  enterocolitis (NEC)54
Hepatic : Hepatomegaly, direct hyperbilirubinemia 
(Jaundice)
Renal :  Oliguria
Hematological : Bleeding, petechiae, purpura, 
spleenomegaly 
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Skin Changes : Multiple pustules, abscess, sclerema, 
mottling, Umblical redness and 
discharge.
LABORATORY INVESTIGATIONS
Blood culture
This  is  the  definitive  test,  as  the  vast  majority  of  neonatal 
infections  are  associated  with  bacteremia.  Conventional  blood  culture 
takes 24-48 hrs to become positive. Prolonged incubation is necessary for 
some  fastidious  organisms  like  Listeria  monocytogenes,  Haemophilus 
influenzae and Yeasts.29
Sample Collection
Preparation of the site
Careful skin preparation before collecting the blood sample is of 
paramount importance to reduce the risk of introducing contaminants into 
blood culture media.
Once  a  vein  is  selected,  the  skin  over  the  venipuncture  site  is 
cleaned using 70% alcohol in a circular fashion. It is then allowed to dry. 
Starting in the centre of the circle, 2% tincture of iodine is applied in ever 
widening circles until the entire circle has been saturated with iodine. It 
is allowed to dry atleast for one minute. 
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The needle is inserted into the vein and blood is withdrawn. After 
the needle has been removed, the site is cleaned with 70% alcohol again, 
as many patients are sensitive to iodine.5
The blood is injected into the blood culture bottle under aseptic 
precautions.
Specimen volume:
For infants and small children only 1 to 5ml of blood is drawn for 
culture. The blood is diluted between 1 in 5 and 1 in 10 in the culture 
medium to reduce concentration of natural antimicrobial constituents to a 
sub effective level.43
Smaller  volumes  of  blood  is  sufficient  since  high  levels  of 
bacteremia (> 1000 cfu per ml of blood) are detected in some  infants.5 
Number of blood cultures
To increase the chance of  isolating pathogen,  the specimens are 
collected at different time intervals. However a study found no significant 
difference  in  the  yield  between  multiple  blood  cultures  obtained 
simultaneously or those obtained at intervals.41
Sample processing
Blood cultures are incubated for 24hrs at 37˚C and observed for 
turbidity. Gram stain is done from the broth. Incubation  periods  are 
extended  if  slow  growing  organisms  are  suspected.84 Apart  from 
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conventional cultures, commercially developed blood culture systems and 
automated systems are also used.43
Buffy coat smear
Gram staining of buffy layer of blood (after centrifugation)  aid in 
the presumptive diagnosis of bacterial pathogens.
Indirect markers of neonatal sepsis:
1. White  cell  counts  –  Leucopenia  (<5000/  cu  mm)  or  absolute  
neutropenia (< 1500/ cu mm)4
2. Band cell count >20% and band count to total neutrophil ratio ≥0.2 
is consistent with infection.
3. Micro ESR- A value of  >15mm is  considered as suggestive of  
infection.75
4. C-reactive protein > 8 µg  is abnormal in the neonate. Measurement 
of  serial  CRP  concentrations  in  serum  may  be  useful  in  the 
treatment of suspected neonatal sepsis.90
5. Presence  of  Dolhe  bodie,  toxic  granules  in  blood  smear  is 
indicative of infection.
6. Platelet count, prothrombin time  and partial thromboplastin time, 
fibrinogen level, arterial blood gas analysis and liver function test.
7. Biochemical  analysis  including  blood  glucose,  urea,  serum 
bilirubin, creatinine and electrolytes are also markers of underlying 
disease.
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Treatment
Institution of prompt treatment is essential for ensuring optimum 
outcome of neonates with sepsis who often reach the health care facilities 
late and in a critical condition. Supportive care and antibiotics are the two 
equally important components of treatment.59
Supportive treatment
1. Warmth  is  provided  to  ensure  consistently  normal  body 
temperature.
2. Intravenous line is started.
3. Normal saline 10 ml / kg is infused over 5-10 minutes, if perfusion 
is poor as evidenced by capillary refill time (CRT) of more than 3 
seconds.
4. Glucose (10%) infusion 2 ml/kg stat.
5. Vitamin k 1 mg is given by intramuscular injection.
6. Nasal oxygen is started by hood or mask, if cyanosed or grunting
7. Gentle physical stimulation is given, if apnoeic 
8. Bag and mask Ventilation with oxygen is provided if breathing     is 
inadequate 
9. Enteral feed is avoided in the very sick,  maintainance fluids are 
given intravenously.
10. Exchange transfusion can be considered, if there is sclerema.
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Specific treatment
Antibacterial Treatment
Antibiotic  therapy  should  cover  the  common  causative  bacteria 
namely  Escherichia  coli,  Staphylococcus  aureus and  Klebsiella  
pneumoniae. A  combination  of  ampicillin  and  gentamicin  is 
recommended  for  treatment  of  sepsis  and  pneumonia.  In  cases  of 
suspected meningitis, chloramphenicol should be added. Third generation 
Cephalosporins such as Cefotaxime and Amikacin are commonly used 
second line antibiotics.
Antifungal Treatment
        Immediately the diagnosis is made or even when there is a high 
level  of  suspicion  of  fungal  infection  in  a  sick  infant,  treatment  with 
antifungals are started.
Amphotericin B is the mainstay of treatment for systemic fungal 
infections.65 Because of the toxicity of Amphotericin,  liposomal form of 
the  durg,  Ambisone  is  preferable  nowadays.  Flucytosine  acts 
synergistically  with  Amphotericin  and  many  authorities  advocate  their 
combined use in the initial treatment of fungal infection in the newborn.
Removal  of  central  venous  catheters  and  discontinuation  of 
intravenous  fat  are  other  measures  which  can  reduce  the  spread  and 
severity of the infections.
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Immunotherapy
1. Neutropenia is commonly observed in infants with proven bacterial 
infections. Granulocyte colony stimulating factor has been shown 
to  resolve  pre-eclampsia  associated  neutropenia  and  may  thus 
decrease the rate of late onset sepsis in this population.63
2. Exchange transfusion.87
3. Fresh frozen plasma.81
4. Antilipid A monoclonal Antibodies.
5. Intravenous immunoglobulin administration.1
6. Anti TNF-α 
7. Interleukin-1 receptor antagonist
Other  complications  like  acidosis,  hypoglycemia  are  treated 
accordingly.
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MATERIALS AND METHODS
Place of study
Institute of Microbiology
Madras Medical College,
Chennai-3
And
Department of Medical Newborn and
Department of Microbiology,
Institute of Child Health and Hospital for Children
Egmore, Chennai-8
Period of Study
Prospective study carried out over a period of one year from June 
2008-May 2009
Study Design
Descriptive study.
Sample Specification
Study population: 150 Newborn babies (<1month old) with clinical 
suspicion of sepsis were included in the prospective study.
A detailed prenatal and postnatal history with special emphasis on 
any predisposing factors for infection and thorough clinical assessment 
were carried  out.
Inclusion criteria:
          Neonates with characteristics indicating probable sepsis:
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1) Temperature > 99 degree F or 95 degree F.
2) Change in behavior - Abnormal cry or does not cry.
                   - Not accepting feed.
- Drowsy or unconscious.
- Seizures
3) Septic focus on umbilicus or skin.
4) Diarrhoea 
5) Rapid respiratory rate >60/mt.
6)  Hospitalised or brought for consultation for other clinical 
illness and developing signs and symptoms of sepsis after 
hospitalization.
Exclusion criteria
1) No signs and symptoms indicating probable sepsis.
2) Prior antibiotic administration.
Methodology
Sample Collection
The skin over the Venipuncture site is cleaned with 70% alcohol 
and 2% tincture of  iodine.  About  0.5-1ml  of  blood was collected  and 
directly  inoculated  into  the  Brain  heart  infusion  broth  and  Robertson 
cooked meat broth with liquid paraffin overlay  under aseptic precautions 
and incubated at 37 degree centigrade for 24hours.
Sample processing
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After 24hrs of incubation, the cultures were examined for turbidity, 
lysis of red blood cells or clotting. From Brain heart infusion broth, a 
Gram smear was made and subcultures were done onto Mac conkey Agar, 
Blood Agar, Chocolate agar and Nutrient Agar and incubated at 37˚C for 
24hrs. Blood agar  and Chocholate agar plates were incubated at 37˚C in 
CO2  environment  (Candle  jar).S/C  were  done  onto  two  Sabouraud’s 
Dextrose Agar slant, one incubated at 37˚C and the other at 22˚C.43
From Robertson cooked meat broth subculture was done onto 5% 
sheep  blood  agar  with  Kanamycin,  Hemin  and  Vitamin  K  and  was 
incubated  under  anaerobic  environment  for  72hours  at  37˚ using 
polycarbonate jar with Gaspak.
All  bottles were reincubated and checked for turbidity daily and 
subcultured whenever there were any signs of growth. A final subculture 
was made on the tenth day on to the above media43 
Examination of subcultures
The plates were examined after incubating for 18-24hrs. When any 
growth was seen, the colony morphology was noted. The colonies were 
identified by
1. Gram stain-  to  identify  gram positive  and  gram negative 
organisms.
2. Hanging drop- to find out motile and non motile organisms.
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3. Preliminary tests like Oxidase, Catalase were performed. 
4. Members  of  the  species  were  identified  based  on 
biochemical  parameters  using  IMViC  reaction  and  sugar 
fermentation medium.
COLONIAL MORPHJOOGY
Klebsiella pneumoniae
Nutrient agar
Large , dome shaped mucoid colonies.
Blood agar
Large , grayish white, mucoid colonies.
Mac Conkey agar
Lactose fermenting mucoid colonies.
Species were identified with biochemical reactions
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BIOCHEMICAL REACTIONS
Indole Negative
Methyl red test Negative
Voges Proskauer Positive
Citrate Utilised
Glucose Acid with gas
Lactose Acid with gas
Sucrose Acid with gas
Maltose Acid with gas
Mannitol Acid with gas
Triple sugar iron Acid / Acid with gas no H2S
Urease Positive
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Escherichia coli:
Nutrient agar :
Colonies  were  1-3  mm  diameter,circular  ,low  convex,  smooth  
colonies with no pigmentation and odour.
Blood agar:
 Greyish white colonies with haemolysis.
Mac Conkey agar:
Flat, lactose fermenting colonies.
Species were identified with biochemical reaction.
BIOCHEMICAL REACTIONS
Indole Positive
Methyl red test Positive
Voges Proskauer Negative
Citrate  Not utilised
Glucose Acid with gas
Lactose Acid with gas
Sucrose Acid with gas
Maltose Acid with gas
Mannitol Acid with gas
Triple sugar iron Acid / Acid with gas no H2S
Urease Negative
Pseudomonas aeroginosa
Nutrient agar:
Colonies were large, low convex with serrated margins, with bluish  
green pigmentation and earthy odour.
Blood agar:
Diffuse hemolysis present.
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Mac Conkey agar:
Non lactose fermenting colonies with pigmentation .
Species were identified by biochemical reactions
Indole Negative
Methyl red test Negative
Voges Proskauer Negative
Citrate   Utilised
Glucose Oxidatively utilised
Lactose Oxidatively utilised
Mannitol Not fermented
Xylose Oxidatively utilised
Triple sugar iron Alkali/ no change in the butt
O-F Test Oxidatively utilised
Urease Positive
Acinetobacter species:
Blood agar:
Smooth, opaque , raised ,creamy colonies.
Mac Conkey agar
Non lactose fermenting colonies.
Indole Negative
Citrate   Utilised
Glucose Not fermented
Triple sugar iron Alkali/ no change in the butt
O-F Dextrose Positive
Urease Negative
Staphylococcus aureus:
Nutrient agar:
Showed  1  to  3  mm  diameter  ,circular,smooth  ,low 
convex,glistening,  densely  opaque  colonies  with  golden  yellow 
pigmentation.
34
Blood agar:
Colonies were surrounded by a narrow zone of beta hemolysis.
Mac Conkey agar:
Colonies were pink and small in size.
Slide Coagulase Test:positive
Tube coagulase test:positive
BIOCHEMICAL REACTIONS
Indole Negative
Methyl red Positive
Voges  Proskauer Positive
Mannitol Fermented
Urease Positive
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Group B Streptococci (Streptococcus agalactiae)
Blood agar: colonies are 1-2mm diameter, grey,mucoid with β type  
of hemolysis
CAMP Test:
A  sterile  blood  agar  plate  was  taken.  A  single  streak  of  
Staphylococcus aureus (β hemolysin producing  Staphylococcus aureus) 
was  made  in  the  centre  of  the  plate.  A  steak  of  the  β  hemolytic  
Streptococcus was made perpendicular to the Staphylococcal streak,such  
that the two organisms were not touching each other. Known group A and  
Group  B  Streptococcal  strains  were  inoculated  in  the  same  plate  as  
negative and positive controls, respectively. The plate was incubated at  
35°C in ambient air for 18-24hours.
An  area  of  increased  hemolysis  occurs  where  the  β  hemolysin  
secreted by Staphylococcus and the CAMP factor secreted by the Group 
B Streptococcus intersect.
Hippurate  hydrolysis:  To  0.4ml  of  1%  solution  of  sodium  
hippurate, a loopful of growth from blood agar was added and incubated  
at 37° C for two hours. After incubation 0.2ml of ninhydrin solution was  
added and incubated at 37°C for 10 minutes. The medium changes into  
purple colour due to hippurate hydrolysis.
Susceptibility to Bacitracin : Resistant.
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Antimicrobial susceptibility tests:
Antimicrobial susceptibility of the isolates were tested using Kirby 
Bauer disc diffusion technique as per CLSI guidelines16.
Medium used :MHA (Muller Hinton Blood agar plate was used for 
GBS isolate) 
Inoculum : 0.5 McFarland turbidity, lawn Culture.
Incubation :  37˚C ambient air, incubated for 16-18 hrs
Preparation of inoculums:
       About 4-5 colonies of the same morphology were picked up with 
straight wire and inoculated in 5ml of peptone water, incubated at 37°C 
for 3-5 hrs to attain 0.5 Mc Farland’s turbidity.5  
A sterile cotton swab was dipped into it and pressed firmly against 
the wall of the test tube to remove excess broth from the swab.
Dried surface of Mueller Hinton Agar plate was swabbed in three 
directions approximately 60° each time to ensure an even and complete 
distribution of the inoculum over the entire plate 
The  anti  microbial  discs  were  dispensed  on  the  agar  plate  and 
pressed down to ensure complete contact with agar surface. Disc  were 
distributed evenly so that they were not closer than 24mm from centre to 
centre. Not more than 6 discs were placed in the plate.
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After  16-18  hrs  of  incubation  each  plate  was  examined.  The 
diameter of the zones of complete inhibition was measured including the 
diameter of the discs. Zones were measured to the nearest whole ‘mm’ 
using a ruler which was held on the back of the inverted petri plate.
Control strains used were
1. Staphylococcus aureus ATCC 25923
2. Escherichia coli ATCC25922
3. Pseudomonas aeroginosa ATCC 29823
Screening of ESBL producing strains for Klebsiella pneumoniae
Clinical  and  Laboratory  Standards  Institute  has  developed 
screening test for identifying the ESBL producing Klebsiella species. 
According to CLSI guidelines, strains showing zones of inhibition 
of  ≤ 22mm for ceftazidine,  ≤ 27mm for cefotaxime were selected for 
conformational  tests  of  ESBL.  Klebsiella  pneumoniae ATCC  700603 
ESBL positive strain was used as control  along with  Escherichia coli 
ATCC 25922 as negative control.
ESBL confirmatory test:
1. Double Disc Synergy test (DDST)30
The isolated colonies were inoculated in peptone water at 37˚C for 
2-6 hrs. The turbidity was adjusted to 0.5 Mc Farlands standard and lawn 
culture was made on Muller Hinton agar using sterile swab. 
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Augmentin disc (20/10 µg) was placed in the centre of plate. Both 
side of Augmentin disc, a disc of cefotaxime (30 µg) and cetazidime (30 
µg)  were  placed  with  centre  to  centre  distance  of  15mm to  centrally 
placed disc. The plate was incubated at 37˚C overnight, ESBL production 
was interpreted as the 3rd generation Cephalosporin disc inhibition was 
increased towards the Augmentin disc or if neither discs were inhibitory 
alone but bacterial growth was inhibited where the two antibiotics were 
diffused together. 
2. Phenotypic  Confirmatory  Disc  Diffusion  Test  (PCDDT)  for  
ESBL89
Antibiotic susceptibility testing was done on Muller Hinton Agar 
with 0.5 Mc Farlands standards of the organism. Lawn Culture of the 
organism  was  made  and  3rd generation  Cephalosporins  Cefotaxime 
(30µg) disc and Cefotaxime with Clavulinic acid (30 µg + 10 µg ) disc 
was  placed with 25mm apart. An increase of ≥ 5mm in zone of inhibition 
for  Cefotaxime  with  Clavulinic  acid  compared  to  Cefotaxime  was 
confirmed as ESBL producers.
Growth in Sabourauds Dextrose Agar is subjected for following tests:
The Sabourauds dextrose agar slopes were examined after 48hrs,  
96 hrs, 5days,7days,14days and one month for the appearance of yeasty  
or mouldy growth.
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GRAM STAIN
Gram positive oval budding yeasts cells with presence or absence 
of pseudohyphae 
GERM TUBE TEST
A loopful of creamy white yeast like colony from SDA was taken 
and it was inoculated in to 0.5ml of mammalian serum. It was incubated 
at 37 degree centigrade for one and a half to 2 hours. After incubation 
period, a loop full of this serum suspension was placed on a clean glass 
slide and covered with cover slip and focused under high power objective 
to see the characteristic germ tube formation .
CHROMAGAR(HIMEDIA)
A single colony from Sabourauds  dextrose agar was taken and it 
was  streaked  on  chromagar  and  incubated  at  37°C  for  48  hrs.  After 
incubation  period  the  plates  were  observed  for  characteristic  coloured 
colonies of candida.
CORNMEAL AGAR
A single colony from Sabouraud’s dextrose agar was inoculated on 
to plate of cornmeal agar containing 1%Tween 80 and trypan blue. Three 
parallel steaks were made about half an inch apart at a 45 degree angle to 
the culture medium. A sterile coverslip was placed over it and incubated 
at 30 degree centigrade for 48 hrs. After incubation the areas where the 
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cuts  into  the  agar  were  made  were  exmined  for  the  presemce  of 
blastoconidia, arthroconidia, pseudohyphae, hyphae or chlamydoconidia.5
Carbohydrate fermentation test
A saline  suspension  of  the  yeast  colonies  was  prepared.  About  
0.2ml  of  this  suspension  was  inoculated  on  to  the  carbohydrate  
fermentation broth that contain Durhams tube and different sugars at a  
concentration of  2%. The different  sugars used were glucose,  lactose,  
sucrose,  maltose  respectively.  The  tubes  were  incubated  at  room 
temperature  for  7-10  days.  After  incubation  period,  the  tubes  were  
observed for acid and gas production.
Carbohydrate assimilation test
Organisms  from  SDA were  inoculated  onto  carbohydrate  free 
meduium  either in nutrient agar or blood agar. A suspension of the yeast 
in saline or distilled water to a density equivalent to a McFarland No.4 
standard  was  prepared.  The  saline  suspension was swabbed  on sterile 
yeast nitrogen base agar plate.5
The different  carbohydrate  disc  used include  glucose  ,  lactose  , 
sucrose,     maltose, galactose, trehalose , raffinose. The disc were placed 
onto the surface of the agar approximately 30mm apart from each other. 
The plates were incubated at 30 degree centigrade for 24 to 48hrs.
41
After incubation, the plates were observed for the presence of a 
colour change around the carbohydrate containing discs or the presence 
of growth surrounding them5 
COLONY MORPHOLOGY
Candida albicans:
Sabouraud’s  dextrose agar:  colonies  were  cream coloured,  pasty  and  
smooth
Gram stain:
Gram  positive  oval  budding  yeasts  cells  with   or  without  
pseudohyphae
Germ tube test: positive
CHROMagar: colonies appear light green
Cornmeal agar:
Pseudohyphae  in  clusters  with  large,  thick  walled,terminal 
chlamydospores.
Carbohydrate fermentation test
Glucose Acid and gas
Maltose Acid and gas
Sucrose Not fermented
Lactose Not fermented
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Carbohydrate assimilation test
Assimilates glucose, maltose, sucrose, lactose, galactose , trehalose 
and xylose
Candida tropicalis:
Sabouraud’s dextrose agar: 
Colonies were cream coloured, pasty, glistening to dull and smooth
Gram stain:
Gram  positive  oval  budding  yeasts  cells  with   or  without 
pseudohyphae 
Germ tube test : negative
CHROMagar:  blue coloured colonies with pink halo.
Cornmeal agar:
Short branched pseudohyphae with blastoconidia 
Carbohydrate fermentation test
Glucose Acid and gas
Maltose Acid and gas
Sucrose Acid and gas
Lactose Not fermented
Carbohydrate assimilation test
Assimilates  glucose,  maltose , sucrose ,  galactose, trehalose   and 
xylose.
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ANTIFUNGAL SUSCEPTIBILITY TESTS:
The antifungal susceptibility tests was done by two methods
1) DISC DIFFUSION METHOD
2) BROTH MICRODILUTION METHOD
Inoculum preparation:
The inoculum suspension was prepared by picking five colonies, 
each of atleast 1mm in diametrer, from 24 hour old culturs of  candida 
species  and  suspending  the  material  in  5ml  of  sterile  saline.  The 
suspension was then adjusted spectrophotometrically at 530nm to match 
the transmittance produced by 0.5 McFarland’s barium sulphate standard. 
This procedure produces an inoculums size 1×  106to 5×  106cfu/ml. 
The same inoculum was used for both methods.60
The  following  standard  strain  was  tested  each  time  to  ensure 
quality control :
Candida albicans ATCC 90028
Disc diffusion method
           It was performed on Muller Hinton agar plate   supplemented with 
2% glucose and 0.5 µg/ml methylene blue14
Antifungal susceptibility testing was carried out following the M 
44-A. National Committee for Clinical Laboratory Standards (NCCLS) 
guidelines, using fluconazole and itraconazole  antifungal discs.
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BROTH MICRODILUTION METHOD
This was done as per CLSI document M 27-A 2 for Yeasts, CLSI, 
Pennsylvania, USA 2002.16
The test was performed in a 96 well  microtitre plate using standard 
RPMI1640 mediun.MIC range of antifungal agents used were 
• Amphotericin B : 0.03 – 16 micro gram/ml
• Fluconazole :  0.125 to 64   micro gram/ml   
For  fluconazole,  Isolates  with  MIC  8  microgram  /ml  were 
considered  susceptible,  values  between  16-32  microgram/  ml  dose 
dependent susceptible and those 64 microgram/ml resistant. Due to the 
lack of defined breakpoints for Amphotericin B, isolates showing an MIC 
of 1.0 µg ml–1  were taken as susceptible and those with MIC >1 µg ml–1 
were  considered  as  resistant67.  The  endpoint  for  Fluconazole  was  the 
lowest concentration  in  which  prominent  decrease  in  turbidity  was 
observed and for Amphotericin B was defined as the lowest concentration 
in which an optically clear well was observed.70   
45
RESULTS
TABLE – 1
AGE DISTRIBUTION OF CASES (n =150)
          55.33 % of Babies had Early onset sepsis and 44.67 % of babies 
had late onset sepsis. There is an almost equal incidence of early and late 
onset sepsis.
TABLE - 2
SEX DISTRIBUTION OF CASES (n=150)
Sepsis  was  more  predominant  in  male  babies  (65.30%)  than  in 
female babies (34.70%).
TABLE - 3
DISTRIBUTION OF CASES ACCORDING TO PERIOD OF 
GESTATION (n=150)
The Number of Term babies with clinical signs of sepsis were 81 
(54%) and Preterm were 69(46%).
TABLE - 4
WEIGHT DISTRIBUTION OF CASES (n=150)
According to National Neonatology forum Standards, Babies were 
considered as  Low birth  weight  if  the  birth  weight  is  <2.5Kg.  In  the 
Present  study 120 (80%) of  the  neonates  belong to  Low birth  weight 
category.
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TABLE -  5
PLACE OF DELIVERY : HOSPITAL VS HOME (n=150)
92.7% of the cases had  hospital delivery.
TABLE - 6
BIRTH ORDER DISTRIBUTION OF CASES.
      
Majority of the Babies with clinical evidence of sepsis were born to 
Primi gravida (48%). 
TABLE -  7
CORELATION BETWEEN PERIOD OF GESTATION AND 
ONSET OF SEPSIS
Period of gestation Early onset sepsis Late onset sepsis
TERM (n=81) 38(46.9%) 43(53.1)
PRETERM(n=69) 45(65.2%) 24(34.8%)
                                                                                                           P=0.02
Early  onset  sepsis  was  observed  more  in  preterm  neonates 
compared to term neonates.this is statistically significant.
TABLE - 8
CORRELATION BETWEEN ONSET OF ILLNESS AND RISK 
FACTORS
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Low birth weight was the most common risk factor for both early 
and late onset sepsis.
LBW-  Low  birth  weight,  CRP-  Child  rearing  practice,  PROM- 
Prematutre rupture of membranes, PIH- Pregnancy induced hypertension.
TABLE - 9
ONSET OF ILLNESS AND CLINICAL MANIFESTATIONS
        
Lethargy, Respiratory distress and seizures were observed to be the 
most common presenting manifestation in both early and late onset group 
of patients. 
TABLE - 10
RESULTS OF BLOOD CULTURE (n=150)
Blood culture was found to be positive in 62 (41.3%) cases.
TABLE  -  11
ORGANISMS ISOLATED BY BLOOD CULTURE IN NEONATES 
WITH SEPSIS (n=62)
Total  culture positive cases were 62.  Gram positive cocci  were 
23(37.1%), Gram negative bacilli were  35  (56.5%) candida was isolated 
in 4 (6.4%) cases.
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TABLE - 12
ANTIBIOTIC SENSITIVITY PATTERN OF GRAM POSITIVE 
ORGANISMS
Organism Pen Ampi Oxa Erythro Cotri Cef Ak Cip Van
Staphylococcus 
aureus
MSSA(n =10)
MRSA (n=5)
10 
(100%)
0
10 
(100%)
0
10 
(100%)
0
10 
(100%)
2(40%)
10
(100%)
3(60%)
10
(100%)
0
10
(100%)
5(100%)
10
(100%)
3(60%)
10
(100%)
5(100%)
Cons (n=4) 2
(50%)
2
(50%)
4
(100%)
3
(75%)
2
(50%)
4
(100%)
4
(100%)
3
(75%)
Enterococci 
(n=2)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
Streptococcus 
agalactiae
(n=2)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
All Staphylococcus  aureus were sensitive to vancomycin.
TABLE  -  13
ANTIBIOTIC SENSITIVITY PATTERN OF GRAM NEGATIVE 
ORGANISMS
Organism AMPI COTRI CEF AK CEFTA ZIDIME GENTA CIP IMI
Klebsiella 
pneumoniae  (n 
=24)
6
(25%)
8
(33.3%)
10
(41.6%)
15
(62.5%)
13
(54.2%)
14
(58.3%)
20
(83.3%)
24
(100%)
Escherichia 
coli (n = 5)
3
(60%)
2
(40%)
3
(60%)
4
(80%)
3
(60%)
3
(60%)
4
(80%)
5
(100%)
Pseudomonas 
aeroginosa 
(n = 4)
1
(25%)
4
(100%)
4
(100%)
4
(100%)
1
(25%)
3
(75%)
4
(100%)
Acinetobacter 
SP(n =2)
2
(100%)
2
(100%
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
All the isolates were sensitive to imipenem.
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TABLE -  14
ESBL SCREENING TESTS FOR GRAM NEGATIVE 
ORGANISMS
(Cefotaxime: zone of inhibition>27mm- sensitive  ,<27mm- resistant; 
Ceftazidime, zone of inhibition>22mm- sensitive,  < 22mm- resistant)
ORGANISM
SUSCEPTIBILITY TO 3rd GCS RESISTANT TO 3rd GCS
No.of isolates Percentage No.of isolates Percentage
Klebsiella pneumonia (n=24) 10 41.6% 14 58.3%
Escherichia coli (n=5) 3 60% 2 40%
Pseudomonas aeroginosa 
(n=4)
4 100% _ _
Acinetobacter sp (n=2) 2 100% _ _
14 isolates of  Klebsiella pneumoniae and 2 isolates of E.coli were 
found  resistant  to  third  generation  cephalosporins  3rd GCS  –  Third 
generation cephalosporins.
TABLE  -  15
COMPARISON OF SCREENING TESTS WITH DDST AND 
PCDDT
Number of screened 
isolates for ESBL DDST PCDDT
Klebsiella pneumoniae 
(n=24) 14(58.3%) 8(33.3%) 9(37.5%)
Escherichia coli    (n=5) 2(40%) 1(20%) 1(20%)
16 Isolates were selected and subjected for confirmatory tests. 10 
Isolates were confirmed as ESBL Producers by PCDDT.
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TABLE - 16
ANTIFUNGAL SUSCEPTIBILITY TESTS BY DISC DIFFUSION 
METHOD
FLUCONAZOLE ITRACONAZOLE
SENSITIVE RESISTANT SENSITIVE RESISTANT
C.albicans(n=3) 3(100%) 0 3(100%) 0
C.tropicalis(n=1) 0 1(100%) 0 1(100%)
Candida tropicalis was found to be resistant to both fluconazole 
and itraconazole.
TABLE -  17
ANTIFUNGAL SUSCEPTIBILITY TESTS BY MICROBROTH 
DILUTION METHOD
AMPHOTERICIN B FLUCONAZOLE
SENSITIVE
(MIC ≤1μg/ml)
RESISTANT
(MIC > 1μg/ml)
SENSITIVE
(MIC <64 μg/ml)
RESISTANT
(MIC >64 μg/ml)
C.albicans 
(n=3)
3(100%) 0 3(100%) 0
C.tropicalis
(n=1)
1(100%) 0 0 1(100%)
Candida albicans were  susceptible  to  both Amphotericin  B and 
Fluconazole.
TABLE : 18
ANALYSIS OF CLINICAL OUTCOME/MORTALITY IN 
NEONATES WITH SEPSIS (n=150)
TOTAL NO. OF CASES 150
RECOVERED 134 (89.3%)
DEATH 16(10.7%)
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10.7% mortality was observed among sepsis cases.
TABLE : 19
CORRELATION OF MORTALITY WITH TERM / PRETERM 
BABIES
                                                                                  
P=0.04
Mortality  is  observed  to  be  high  in  preterm  Babies 
(17.4%),Whereas  in  term Babies,  it  is  less  (4.9%).This  is  statistically 
significant.
TABLE  -  20
ORGANISM ASSOCIATED WITH THE MORTALITY IN 
NEONATAL SEPSIS (n=16)
Total no. 
of deaths
ORGANISM ISOLATED
Klebsiella 
pneumoniae
Pseudomonas
aeroginosa
Staph. 
aureus
E.coli Candida No growth
16 6(37.5%)
2(12.5%) 2(12.5%) 2(12.5%) 2(12.5%) 2(12.5%)
There  were  a  total  of  16  deaths  in  the  study,  out  of  which  10 
(62.5%)deaths were due to gram negative septicemia.
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DISCUSSION
The study was done at Institute of Microbiology, Madras Medical 
College  and  Institute  of  Child  Health  and  Hospital  for  children.  150 
newborn babies less than 30 days of age suspected to have sepsis were 
included in the study. Diagnosis of sepsis was arrived at on the basis of 
clinical examination.
Number  of  babies  with early  onset  sepsis  was  55.33% and late 
onset sepsis was 44.67%.This is similar to Meharban Singh et al47 study 
where there is equal distribution of early and late onset cases.
According  to  age  and  sex  distribution,  neonatal  infection  was 
predominant  in  male  babies  (65.3%)  as  compared  to  female  babies 
(34.7%). This correlated with the study conducted by H.William Teausch 
et al who found that92 that neonatal septicemia was more common in male 
babies. S.S.Keshari et al36 reported that the incidence of neonatal sepsis 
was  predominant  in  male  babies  (63.01%)  which  correlated  with  the 
present study.
In the present study neonatal sepsis was more common in Primi 
Gravida (48%) followed by second Gravida (26%) which is in accordance 
with the finding that Primiparity is a risk factor for sepsis.  Shah GS et al 
reported a higher incidence (72%) of neonatal sepsis in primi gravida. 73
In this study the major risk factors for neonatal sepsis were low 
birth weight (80%) and prematurity(46%). Other risk factors found were 
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Rupture of membranes and delivery interval more than 12 hours (14%), 
bad child rearing practices (8%), pregnancy induced hypertension (6%) 
and cord around neck (2.6%).
Low  birth  weight  and  prematurity  have  been  reported  to  be 
important risk factors for neonatal sepsis21,22,45 & 71.
          Prematurity is a statistically significant risk factor for early onset 
sepsis in the present study.
Nathoo KJ et al 199055 reported that following were the risk factors 
for  neonatal  septicemia,  poor  antenatal  care  and prolonged  rupture  of 
membrane, whereas Tessin I et at 1990 reported that preterm delivery was 
a more important risk factor for both morbidity and mortality83.
The common clinical manifestations found in cases in this study 
Were  lethargy  (48.7%),  respiratory  distress  (42.1%),  fever  (30.7%), 
Jaundice  (28%),  seizure  (24.6%),  poor  cry  (23.3%),  vomiting  and 
diarrhoea (9.3%). Our study correlates with the study of Singhal PK et al 
199280 who reported lethargy (81.4%), respiratory abnormalities (41.9%) 
and seizures (30.2%) as the most common clinical manifestations.
Jain N K et al also reported that common presentations found in 
neonatal  sepsis  were  respiratory  distress  (42.6%),  lethargy  (40%), 
jaundice (30%), fever (28.3%) and poor feeding (26.7%).28
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In the present  study blood cultures were positive in  41.3%  of 
cases. Aerobic gram-negative bacteremia was found in 56.5% cases. The 
predominant  isolate  was  Klebsiella  pneumoniae (38.7%).Others  were 
Escherichia-Coli  8.1%,  Pseudomonas  aeroginosa 6.5%  and 
acinetobacter  species  3.2%.  Gram-positive  bacteremia  was  found  in 
37.1%  cases.  Staphylococcus  aureus  was  the  predominant  isolate 
(24.2%),  followed  by  Coagulase  negative  staphylococci (6.5%), 
Enterococci  species  (3.2%) and   Streptococcus  agalactiae (3.2%).  No 
anaerobes were isolated in the present study.
Fungal isolates  found were 6.4% .Candida albicans was isolated 
in 3cases  and Candida tropicalis  in 1case.
A study  conducted  by  Kumhar  GD et  al  showed  blood  culture 
positivity  of  42.1%.The  predominant  isolates  were  Klebsiella 
pneumoniae 33.8%   and   Staphylococcus aureus  24.4%.The present 
study correlates well with these findings38.
Roy  et  al  observed  that  the  most  frequent  offender  in  neonatal 
sepsis were Klebsiella species(24.6%) followed by Enterobacter species 
(22.9%),  Coagulase  negative  staphylococci (16.6%),  Staphylococcus 
aureus  (14%) and  Escherichia coli (14%)70.  Narang  A, Kumar P et al 
reported Staphylococcus aureus (23%) as commonest isolate both in early 
and late onset sepsis53.
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Out  of  15  strains  of  Staphylococcus  aureus,10(66.7%)  showed 
sensitivity to oxacillin (1µg disc) by disc diffusion method; Methicillin 
Sensitive  Staphylococcus  aureus (MSSA) strains were also sensitive to 
Penicillin  (100%),  Ampicillin  (100%),  Cotrimoxazole  (100%), 
Ciprofloxacin (100%)  Amikacin (100%), and Erythromycin(100%).
The  other  5(33.3%)  Strains  of  Staphylococcus  aureus  showed 
resistance to Oxacillin (1µg disc) and were sensitive to Vancomycin.
Coagulase  negative  staphylococci were  sensitive  to  penicillin 
(50%),  ampicillin  (50%),  cotrimoxazole  (50%)  and  erythromycin 
(75%).all strains were sensitive to oxacillin.
Group  B  Streptococci were  sensitive  to  Penicillin  (100%), 
Ampicillin  (100%),  Cotrimoxazole(100%),  Ciprofloxacin  (100%)  and 
Erythromycin (100%).
Among  the  gram-negative  organisms,  58.3%  of  Klebsiella 
pneumoniae  and 40% of Escherichia coli were found as ESBL producers 
by screening method. 
By Phenotypic Confirmatory Disc Diffusion Test ( PCDDT) 37.5% 
Klebsiella pneumoniae  and 20% of Escherichia coli were confirmed as 
ESBL producers.  All strains were sensitive to Imipenam .80% isolates 
among the ESBL producers showed sensitivity to ciprofloxacin 
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A Bhattacharjee  et al reported that out of 16 isolates of Klebsiella 
pneumoniae, 100%  were  screened  positive  for  ESBL,  whereas  only 
62.5% were confirmed as ESBL producers by PCDDT11.
CS Vinodkumar et al reported Extended spectrum beta lactamases 
(27%) among gram-negative isolates, Klebsiella pneumonia (48.6%) was 
the most  frequent  ESBL producing organism followed by  Escherichia 
coli (16.8%)  and  Pseudomonas species (13.1%) which correlates with 
our study89.
In  the  present  study  Pseudomonas  aeruginosa were sensitive  to 
Amikacin  (100%),  ceftazidime  (100%)  ciprofloxacin  (75%)  and 
gentamycin (25%).
Acinetobacter species  isolated  from  two  cases  showed  100% 
sensitivity to amikacin, cefotaxim, ciprofoxacin and cotrimoxazole.
Candida  albicans was  reported  in  3(4.8%)  cases  and  Candida 
tropicalis (1.6%)  in  one  case  in  the  present  study.  This  is  similar  to 
Narain et  al  found that among neonatal  candidemia,  Candida albicans 
(54.4%)  was  the  most  common  isolate  from  neonates  followed  by 
Candida tropicalis ( 23.3%) and Candida krusei (23.3%). Makhoul et al 
reported Candida tropicalis  as the causative agent for 20% of episodes of 
neonatal fungemia44.
Scott K et al reported, Candida albicans  blood stream infections 
were most common (57.9%), followed by Candida parapsilosis(33.7%), 
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Candida tropicalis (3.8%), Candida lusitaniae (2.3%), Candida glabrata 
(2%), and  Candida  krusei (0.2%) among the neonates.
Both  Candida  albicans and  Candida  tropicalis showed  100% 
Sensitivity to Amphotericin B. Fluconazole resistance was observed in 
Candida tropicalis isolate.
A  study conducted by Law D et al reported that Candida tropicalis  
(48%) were resistant to fluconazole39.                
Narain  et  al  reported  that  all  neonatal  candidal  isolates  were 
sensitive to Amphotericin B(100%)51.
There  were  a  total  of  16  deaths  in  the  present  study.  12(75%) 
deaths  in  preterm  babies  and  4  (25%)  deaths  in  term  babies.  The 
Mortality  was  higher  in  preterm  neonates  which  was  statistically 
significant
Out  of  16  deaths,  62.5%  deaths  were  due  to  gram  negative 
organisms,  12.5%  due to  Staphylococcus aureus and 12.5%deaths by 
candida. Culture was negative in 12.5% of neonatal deaths.  Pengsaa K et 
al 1996 found a mortality rate of 67.7% which is more than the mortality 
rate of this study61. Clemente Yago F et al 1992 reported a mortality rate 
7.6% which is almost similar to our finding. Airede et al 1992(2) reported 
mortality rate of 27.3%13.
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In the present study among the 16 deaths, 12.5%were due to ESBL 
producing Klebsiella pneumoniae. 
Siu  LK   et  al  reported  25%  mortality  among  the  Neonatal 
septicemic cases due to ESBL producing Klebsiella pneumoniae79
The incidence of candidemia in my study was 12.5%.The mortality 
among the  culture positive cases were 50%.. This is similar to the study 
by  Jyotsna  Agarwal  et  al  who  reported  mortality  rate  was  52.6%  in 
culture proven significant candidemia group34.
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SUMMARY & CONCLUSION
A prospective study was undertaken over a period of one year in 
150 neonates to determine the bacterial and fungal isolates of neonatal 
sepsis.
Lethargy  (48.7%)   and  Respiratory  distress(42.15%)  were  the 
predominant presenting clinical findings. Preterm and low birth weight 
babies carried the highest risk of infection.
The spectrum of bacterial isolates  among the neonatal sepsis were 
Gram positive cocci  37.1% and Gram negative bacilli  56.5% .
  Fungi  contributed to the remaining 6.4%.
The  commonest  organisms isolated  were  Klebsiella  pneumoniae 
(38.7) and Staphylococcus aureus  (24.2%).
The  incidence  of  ESBL producing  Klebsiella  pneumoniae and 
Escherichia coli  were  37.5% and 20% respectively.  All  strains were 
sensitive to Imipenam. 
80% of Gram negative bacilli  were sensitive to Amikacin,   and 
Ciprofloxacin.
Among  the  Staphylococcus  aureus,  66.7%  were  methycillin 
sensitive and  33.3% were methycillin resistant.
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Candida  was  found  in  6.4% of  culture  proven  septicemia.  The 
commonest  being  Candida  albicans (75%).Candida  tropicalis 
contributed to the remaining 25%.
All candida isolates were sensitive to Amphotericin B.
The overall mortality rate was 10.7%.
      Presence of methycillin resistant Staphylococcus aureus and Extended 
spectrum β lactamase  producing gram negative  bacilli  in  the  neonatal 
ward is of grave significance.
Continued surveillance of neonatal septicemia is mandatory due to 
the  changing  pattern  of  causative  organisms  and  their  antimicrobial 
susceptibility pattern.     
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PROFORMA
1. Reg number:
2. Name:
3. Age:
4. Address:
5. Birth order:
6. Risk factors:
a) MRO
b) Booked
c) Unbooked
7. Previous pregnancy:
a) Normal
b) Stillbirth
c) Neonatal death.
8. H/o Vaginal discharge:
a) Serous
b) Purulent
c) Mucus
d) Nil
9. Rupture of membrane and delivery interval(in hours
10. Mode of delivery
a) Hospital delivery-L.S.C.S or Normal delivery
b) Home delivery.
11. Nature of liquor:
a) Meconium stained
b) Foul smelling
c) Normal
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12. Fever :
a. Antenatal:
b. Postnatal ( within 24 hours ) 
13.     Present age of baby.
14. Gestational age of baby at birth:
15. Number of babies:
16. Birth weight: < 1000 gms: <1001- 1500gms: <1501- 
2000gms: <2001 - 2500gms: <2501 - 3000gms: > 3001 
gms:
17. General Condition:
* Eyes: *R.R: *H.R:
* Ear discharge:
* Umbilicus:
* Apnea spell:
* Pallor :
* Cyanosis:
* Jaundice:
18. Respiratory distress:
19. Cardiovascular system:
20. Abdominal distention: Liver:
spleen:
21. Anterior fontanel:
1. Normal :
2. Bulging:
3. depressed;
22. Head circumference:
1. Normal :
2. Increased
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23. Neonatal reflexes : Present / Absent
24. Any midline Swelling along with spine on the back : 
Present   / Absent
25. Irritability : Present / Absent
26. Seizures : Present / Absent
27. Lethargy : Present / Absent
28. Poor Feeding : Present / Absent
29. Skin
30. Osteomyelitis :
31. Septic arthritis : 
INVESTIGATIONS
Blood : 
1. Complete Blood Count
2. Blood Sugar :
Electrolytes :
Blood Urea 
Creatinine
3. Blood culture
4. Antibiotic / Antifungal  susceptibility
Urine
Albumin :
Sugar
Deposit
TREATMENT :
Antibiotic / Antifungals administered 
Condition at the time of discharge
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APPENDIX - I
CULTURE MEDIA
BRAIN HEART INFUSION BROTH   
Sodium citrate lgm
Sodium chloride 4gm
Sodium phosphate 5gm
Dextrose l0 gm
Peptone   1 0gm
BRAIN HEART INFUSION
Brain infusion broth 250ml
Heart infusion broth 750ml
Sodium polyanethol sulphonate 0.25gm
Obtain Ox brain and heart. Remove all fat from the heart. Cut into 
small pieces and grind. Add distilled water three times and keep at 4°C 
overnight.
From  the  brain,  remove  meninges  fully  and  then,  weigh.  Add 
distilled water and mash by using hand. Keep in the cooler over night.
Next morning boil the brain and heart separately for 30 minutes. 
Then filtered through cotton layer. Measure each broth separately. Mix 
both infusions and the remaining ingredients. Dissolve well and adjust pH 
of the entire amount to 7.4 to 7.6.
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Autoclave at 121° C for 15 minutes. Filter through filter paper and 
distribute  in  screw-capped bottles  in  50  to  100ml  amounts.  Autoclave 
once more at 115° C for 10 minutes.
ROBERTSON’S COOKED MEAT MEDIUM
Beef infusion broth
Minced and dried meat
Fat and connective tissue were removed from lean meat. Meat is 
mixed with 2 parts of water and refrigerated over night and any remaining 
fat is skimmed off. Boiled for 30 minutes. The mixture is filtered through 
2 layers of gauze and the meat particles were dried. pH is adjusted to 7.4 
to 7.6.
The dried meat  particles  were distributed  in  12 X 100 mm test 
tubes to a height of 1.5 to 2.5 cm .The pH adjusted filtrate was then added 
to get 3-4 parts liquid per tube. The tubes were plugged and sterilized by 
autoclaving.
BLOODAGAR
Sterile Defibrinated sheep blood -7 ml 
Nutrient Agar (melted)       -100ml
Nutrient  agar  was  cooled  to  about  45-50  °C,  5-7ml  of  sterile 
defibrinated sheep blood was added. Mixed well and 15 ml of blood agar 
was poured in petri dishes.
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CHOCOLATE AGAR
Sterile defibrinated blood - 10 ml 
Nutrient Agar (melted)    -100 ml
When the temperature was about 75°C,  sterile blood was added 
with constant agitation. After addition of blood, kept in water bath and 
heating was continued till the blood changed to chocolate colour. Cooled 
to about 50° C and poured about 15ml  into petri  dishes with  sterile 
precaution.
MACCONKEY AGAR
Peptone - 2 gm
Sodium chloride - 2 gm
Bile salt - 0.5 gm
Lactose - 1 gm
Agar - 1.5 gm
Distilled water - 100 ml
All the ingredients except lactose were dissolved in distilled water 
by heating. pH adjusted to 7.6.1 ml of 1% neutral red solution was added 
to every 100 ml of medium with lactose and sterilized by autoclaving at 
121°C for 15 minutes.
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MEDIA FOR BIOCHEMICAL IDENTIFICATION OF BACTERIA
Oxidase Catalase
Indole Triple Sugar Iron agar
Citrate Urease
Methyl Red – Voges Proskauer Nitrate reduction
Phenyl alanine deaminase test Carbohydrate fermentation 
Media
1. OXIDASE REAGENT
Tetra methyl P - phenlene diamine dihydro chloride -1% aqueous
solution.
2. CATALASE TEST
3% Hydrogen peroxide
3. INDOLE REAGENT
Kovac's reagent
Para dimethyl amino benzaldehyde     - l0gm
Iso amyl alcohol - 150ml
Hydrochloric acid - 80 ml
4. TRIPLE SUGAR IRON AGAR
Sodium chloride 0.5gm
Yeast extract 0.5gm
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Peptone 2gm
Agar 1.5gm
Distilled water 100ml
Distilled  by  keeping  in  boiling  water  bath  and  the  following 
ingredients were added.
Lactose l.0gm
Sucrose l.0gm
Dextrose 0.1 gm
Sodium thio sulphate 0.03gm
Ferrous sulphate 0.02 gm
pH adjusted to 7.6. Phenol red 0.0024 gm (2.4 ml of 1% solution) 
was  added  and  distributed  into  test  tubes  in  4  ml  quantities  and 
autoclaved. The tubes were kept in a slanting position so that to get a 
deep butt and a short slant.
5. SIMMON'S CITRATE AGAR
Sodium Chloride 5.0g
Magnesium sulphate 0.2g
Ammonium dihydrogen phosphate l.0g
Potassium dihydrogen phosphate l.0g
Sodium citrate 5.0g.
Agar 20.0g
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Bromothymol blue (1/500 aqueous solution) 40 ml
Distilled water 100 ml.
The ingredients were mixed and pH adjusted to 6.9.Sterilized by 
autoclaving and poured into tubes as slopes.
6. CHRISTENSEN'S UREA AGAR 
Urea Solution
Sodium Chloride -5.0g
Dextrose -l.0gm
Trypticase -l.0gm
Mono potassium phosphate       -2.0gm
Urea -20.0gm-
Distilled water -100ml
Phenol red 1% solution -1.2 ml (in 
alcohol)
Urea agar base
Agar -1.5 gm
Distilled water - 90 ml
The ingredients were dissolved in distilled water. pH adjusted to 
6.8. Phenol red solution was added & sterilized by filtration. This is stock 
solution.
Agar was dissolved in distilled water and sterilized by autoclaving. 
Cooled to 45° C and 10 ml of urea solution was added, dispensed in 3-5 
ml quantities and allowed to form a small butt and a long slant.
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7. GLUCOSE PHOSPHATE BROTH (MR-VP medium)
Dipotassium phosphate 5.0gm
Glucose 5.0gm
Distilled water 100ml
The above ingredients were suspended in distilled water and heated 
slightly to dissolve them. Sterilized at 11 5° C for 1 5 minutes.
8. POTASSIUM NITRATE BROTH
Potassium nitrate (KN03) 0.2gm
Peptone 5.0gm
Distilled water 100ml
The above ingredients were mixed and transferred into tubes in 5 
ml amount and autoclaved.
9. PHENYL ALANINE DEAMINASE TEST
Yeast Extract 3g Dl-Phenylalamine 2 g
Disodium hydrogen phosphate lg Sodium Chloride - 5 g
Agar 12g Distilled water - 1 lr
pH  adjusted  to  7.4,  distributed  in  tubes  and  sterilized  by 
autoclaving at 121° C for 1 5 minutes, allowed to solidify as long slopes.
MEDIA FOR  TESTING  ANTIBIOTIC  SENSITIVITY PATTERN 
Mueller - Hinton Agar
Beef extract 20.0gm
Acidicase peptone 7.5gm
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Starch l.5gm
Agar 17.0gm
Distilled water        1000ml
The ingredients were dissolved in one liter of distilled water, mixed 
thoroughly. Heated with frequent agitation and boiled for 1 minute. pH 
adjusted to 7.4 +/0.2.Sterilized by autoclaving and poured m plates.
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APPENDIX - II
Sabouraud’s Dextrose Agar With Antibiotics
Composition of Sabouraud’s Dextrose Agar (Emmons Modification)
Dextrose : 20 gm
Peptone : 10 g
Agar : 20 g
Distilled water : 1000 ml
Final pH : 6.9
The  ingredients  are  dissolved  by  boiling.  Gentamycin  was 
dissolved  in  10  ml  of  95%  alcohol  and  added  to  boiling  medium. 
Autoclave at 121°C for 15 minutes, dispense in tubes and allow to cool in 
slanted position.
CORNMEAL AGAR
Cornmeal            40g
Agar                      15g
Water                    1 litre
Boil the cornmeal in 1 litre of water for 60 min.Filter through muslin and 
add  the  agar.  Steam  to  dissolve,  dispense  in  required  amounts  and 
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autoclave  at  115° C  for  30min.  allow  to  cool  to  50°C   and  pour 
approximately 20 ml amounts into Petri dishes. 
SUGAR FERMENTATION MEDIUM
Peptone                      15g
Andrade’s indicator   10 ml
Sugar to be tested       20g
Water                          1litre
Andrade’s indicator is prepared from 0.5% aqueous acid fuchsin to which 
sufficient 1M sodium hydroxide has been added to turn the colour of the 
solution yellow.
Dissolve the peptone and Andrade’s  indicator in 1litre of water and add 
20g of the sugar; sugars to be tested generally include glucose ,sucrose, 
lactose  and  maltose.  Distribute  3ml  amounts  in  standard  test  tubes 
containing an inverted Durham tube. Sterilize by steaming at 100 degree 
C for 30 min on 3 consecutive days.
SUGAR ASSIMILATION AGAR
Basal medium I
Yeast nitrogen base(Difco)
Agar
Water
Steam to dissolve and dispense in 10ml amounts in universal containers. 
Autoclave  at 115 degree C  for 15min.
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ABBREVIATIONS
ESBL                      -         Extended Spectrum  Beta Lactamases
DDST                      -        Double Disk Synergy Test
PCDDT                   - Phenotypic Confirmatory Disc Diffusion Test
LBW                       -         Low Birth Weight
NICU                      -         Neonatal Intensive Care Unit
CRP                        -         Child Rearing Practice
PROM                    -         Premature Rupture Of Membranes
PIH                         -         Pregnancy Induced Hypertension
MIC                        -         Minimum Inhibitory Concentration
G1                           -         Primi gravida
 G2                          -         Second gravida
 G3                          -         Third gravida 
G4                           -         Fourth gravida
G5                           -         Fifth gravida
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